Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Alternet Systems, Inc. (ALYI): Global Mobile Payment Market to Grow to $2.8 Trillion By 2020

Digital, mobile and card payment platforms continue their steady growth behind vastly improved technologies and advancing secure solutions, with experts believing the trend will take hold of the mainstream market in 2016. News, purchase orders, product updates and current events of note in the markets today involve NXT-ID, Inc. (NASDAQ: NXTD), Heartland Payment Systems Inc. […]

International Stem Cell Corporation (ISCO) Commences Enrollment of Phase I Trial of ISC-hpNSC

Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) took a major step in the development of its human parthenogenetic stem cell-derived neural stem cells (ISC-hpNSC) for the treatment of moderate to severe Parkinson’s disease when it announced the commencement of enrollment for its upcoming phase I clinical trial. This announcement followed the Melbourne […]

Content Checked Holdings, Inc. (CNCK) Partners with Leading Capital Markets Advisory Firm

Before the opening bell, Content Checked Holdings, Inc. (OTCQB: CNCK) announced a strategic partnership with leading New York City-based capital markets advisory firm PCG Advisory Group (PCG). Following this announcement, PCG is expected to serve as an advisor for the company’s ongoing investor relations, social media and public relations strategies. “Our search for a partner […]

 

From Our Blog

VERAXA Biotech AG (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

August 27, 2026

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, and Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, have reached an early research milestone in their collaboration to develop antibody oligonucleotide conjugates (“AOCs”), providing VERAXA with an initial proof point for applying its […]

Rotate your device 90° to view site.